vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and Simpson Manufacturing Co., Inc. (SSD). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $588.0M, roughly 1.9× Simpson Manufacturing Co., Inc.). Simpson Manufacturing Co., Inc. runs the higher net margin — 15.0% vs -127.8%, a 142.8% gap on every dollar of revenue. On growth, Simpson Manufacturing Co., Inc. posted the faster year-over-year revenue change (9.1% vs -2.5%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -0.8%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Simpson Manufacturing Company is a leading building materials manufacturer in the United States that produces structural connectors, fasteners, anchors, and products for new construction and retrofitting.
PRGO vs SSD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $588.0M |
| Net Profit | $-1.4B | $88.2M |
| Gross Margin | 32.6% | 45.2% |
| Operating Margin | -116.0% | 19.5% |
| Net Margin | -127.8% | 15.0% |
| Revenue YoY | -2.5% | 9.1% |
| Net Profit YoY | -3093.9% | 13.3% |
| EPS (diluted) | $-10.23 | $2.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $588.0M | ||
| Q4 25 | $1.1B | $539.3M | ||
| Q3 25 | $1.0B | $623.5M | ||
| Q2 25 | $1.1B | $631.1M | ||
| Q1 25 | $1.0B | $538.9M | ||
| Q4 24 | $1.1B | $517.4M | ||
| Q3 24 | $1.1B | $587.2M | ||
| Q2 24 | $1.1B | $597.0M |
| Q1 26 | — | $88.2M | ||
| Q4 25 | $-1.4B | $56.2M | ||
| Q3 25 | $7.5M | $107.4M | ||
| Q2 25 | $-8.4M | $103.5M | ||
| Q1 25 | $-6.4M | $77.9M | ||
| Q4 24 | $-44.4M | $55.4M | ||
| Q3 24 | $-21.0M | $93.5M | ||
| Q2 24 | $-108.4M | $97.8M |
| Q1 26 | — | 45.2% | ||
| Q4 25 | 32.6% | 43.4% | ||
| Q3 25 | 36.1% | 46.4% | ||
| Q2 25 | 34.4% | 46.7% | ||
| Q1 25 | 37.6% | 46.8% | ||
| Q4 24 | 33.9% | 44.0% | ||
| Q3 24 | 37.2% | 46.8% | ||
| Q2 24 | 37.0% | 46.7% |
| Q1 26 | — | 19.5% | ||
| Q4 25 | -116.0% | 13.9% | ||
| Q3 25 | 7.0% | 22.6% | ||
| Q2 25 | 4.3% | 22.2% | ||
| Q1 25 | 4.5% | 19.0% | ||
| Q4 24 | 10.0% | 14.8% | ||
| Q3 24 | 7.4% | 21.3% | ||
| Q2 24 | -2.5% | 22.1% |
| Q1 26 | — | 15.0% | ||
| Q4 25 | -127.8% | 10.4% | ||
| Q3 25 | 0.7% | 17.2% | ||
| Q2 25 | -0.8% | 16.4% | ||
| Q1 25 | -0.6% | 14.5% | ||
| Q4 24 | -3.9% | 10.7% | ||
| Q3 24 | -1.9% | 15.9% | ||
| Q2 24 | -10.2% | 16.4% |
| Q1 26 | — | $2.13 | ||
| Q4 25 | $-10.23 | $1.34 | ||
| Q3 25 | $0.05 | $2.58 | ||
| Q2 25 | $-0.06 | $2.47 | ||
| Q1 25 | $-0.05 | $1.85 | ||
| Q4 24 | $-0.32 | $1.31 | ||
| Q3 24 | $-0.15 | $2.21 | ||
| Q2 24 | $-0.79 | $2.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $341.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $2.1B |
| Total Assets | $8.5B | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $341.0M | ||
| Q4 25 | — | $384.1M | ||
| Q3 25 | $432.1M | $297.3M | ||
| Q2 25 | $454.2M | $190.4M | ||
| Q1 25 | $409.9M | $150.3M | ||
| Q4 24 | $558.8M | $239.4M | ||
| Q3 24 | $1.5B | $339.4M | ||
| Q2 24 | $542.8M | $354.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $300.0M | ||
| Q3 25 | — | $371.3M | ||
| Q2 25 | — | $376.9M | ||
| Q1 25 | — | $382.5M | ||
| Q4 24 | — | $388.1M | ||
| Q3 24 | — | $393.8M | ||
| Q2 24 | — | $399.4M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $2.9B | $2.0B | ||
| Q3 25 | $4.4B | $2.0B | ||
| Q2 25 | $4.5B | $1.9B | ||
| Q1 25 | $4.4B | $1.9B | ||
| Q4 24 | $4.3B | $1.8B | ||
| Q3 24 | $4.6B | $1.9B | ||
| Q2 24 | $4.5B | $1.8B |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $8.5B | $3.1B | ||
| Q3 25 | $10.1B | $3.0B | ||
| Q2 25 | $10.1B | $3.0B | ||
| Q1 25 | $9.8B | $2.8B | ||
| Q4 24 | $9.6B | $2.7B | ||
| Q3 24 | $11.2B | $2.9B | ||
| Q2 24 | $10.4B | $2.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | — |
| Free Cash FlowOCF − Capex | $148.6M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $175.4M | $155.7M | ||
| Q3 25 | $51.7M | $170.2M | ||
| Q2 25 | $75.9M | $125.2M | ||
| Q1 25 | $-64.5M | $7.6M | ||
| Q4 24 | $312.6M | $115.8M | ||
| Q3 24 | $42.2M | $103.3M | ||
| Q2 24 | $9.5M | $111.1M |
| Q1 26 | — | — | ||
| Q4 25 | $148.6M | $119.0M | ||
| Q3 25 | $29.8M | $133.9M | ||
| Q2 25 | $56.7M | $87.3M | ||
| Q1 25 | $-90.0M | $-42.6M | ||
| Q4 24 | $274.9M | $60.3M | ||
| Q3 24 | $15.1M | $58.1M | ||
| Q2 24 | $-18.9M | $70.9M |
| Q1 26 | — | — | ||
| Q4 25 | 13.4% | 22.1% | ||
| Q3 25 | 2.9% | 21.5% | ||
| Q2 25 | 5.4% | 13.8% | ||
| Q1 25 | -8.6% | -7.9% | ||
| Q4 24 | 24.2% | 11.7% | ||
| Q3 24 | 1.4% | 9.9% | ||
| Q2 24 | -1.8% | 11.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 6.8% | ||
| Q3 25 | 2.1% | 5.8% | ||
| Q2 25 | 1.8% | 6.0% | ||
| Q1 25 | 2.4% | 9.3% | ||
| Q4 24 | 3.3% | 10.7% | ||
| Q3 24 | 2.5% | 7.7% | ||
| Q2 24 | 2.7% | 6.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.77× | ||
| Q3 25 | 6.89× | 1.58× | ||
| Q2 25 | — | 1.21× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 2.09× | ||
| Q3 24 | — | 1.10× | ||
| Q2 24 | — | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
SSD
Segment breakdown not available.
